Bristol-Myers Squibb (BMY)

$71.09 0.62 (0.86%)

19:00 EDT BMY Stock Quote Delayed 30 Minutes

7 Screaming Buy Stock Picks to Beat the September Market Slump

By Chris Lau, InvestorPlace Contributor Sep 13, 2022

Savvy investors will take advantage of the stock market weakness and panic selling to accumulate discounted screaming buys.

Biotech Stocks Stand to Benefit as Biden Announces Support for Industry

Bristol-Myers Squibb (BMY) Stock Jumps 8% as FDA Approves Psoriasis Treatment

7 Blue-Chip Stocks to Buy Before the Bull Market Returns

Volume:

Previous Close -

Market Cap 157.97B

PE Ratio 23.62

EPS 3.01

Volume (Avg. Vol.) 11.35M

Day's Range $70.98 - $72.11

52-Week Range $53.22 - $80.59

Dividend & Yield $1.96 (2.76%)

BMY Stock Predictions, Articles, and Bristol-Myers Squibb News

From InvestorPlace
From the Web

5 Stocks That Michael Burry Just Dumped From His Portfolio

By Thomas Niel, InvestorPlace Contributor Sep 1, 2022

During the preceding quarter, Michael Burry cashed out of eleven other U.S.-listed stocks. Let's take a look at five of his largest prior holdings, and see why he may have saw it as wise to take the money and run.

7 Best Cash Cow Stocks to Buy for Stable Returns

By Tezcan Gecgil, InvestorPlace Contributor Jul 24, 2022

Investors seeking shelter from the market selloff through 2022 can take a look at some of the best cash cow stocks to buy.

7 Best Pharmaceutical Stocks to Buy Now

By Muslim Farooque, InvestorPlace Contributor Jul 20, 2022

These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world.

Best Stocks for 2022: After Two Quarters, Who Holds The Lead?

By Avril Ayers, Web Editor Jul 17, 2022

After the first two quarters of fiscal year 2022, who holds the top spot in the InvestorPlace Best Stocks for 2022 contest? Let's dive in.

Best Stocks for 2022: Bristol-Myers Squibb Is Having a Great Year

By Sure Dividend Jul 8, 2022

BMY stock is up 21% this year. That's impressive compared to the market as a whole, which has entered bear territory, and it has room to grow.

6 Stocks Hedge Funds Love in a Recession

By Mark R. Hake, CFA Jul 6, 2022

6 stocks hedge funds love in a recession, including the top 3 holdings from Michael Burry and Leon Cooperman.

5 S&P 500 Stocks Ready to Break Out

By Tyler Craig, Tales of a Technician Jun 29, 2022

Although Wall Street is hurting right now, not all S&P 500 stocks are getting thrashed. And these beauties are getting ready to break out.

7 Blue-Chip Stocks With Strong Dividend Yields

By Alex Sirois Jun 9, 2022

Blue-Chip stocks are particularly attractive in volatile times like now. These picks include a strong dividend as well.

7 Cheap Growth Stocks That Won’t Stay That Way for Long

By Chris Lau, InvestorPlace Contributor Jun 6, 2022

Investors foolishly sent these stocks into cheap territory, ignoring the near-term growth prospects that will reward them soon.

6 Biotech Stocks to Buy Now Ahead of These June Catalysts

By Shanthi Rexaline Jun 3, 2022

Biotech investors stand to make a windfall if they make calculated bets by thoroughly researching on key catalysts that could move the stocks in a big way.

The Top 10 Stocks Helping Warren Buffett Beat the Market

By Patrick Sanders, InvestorPlace Contributor May 11, 2022

These Warren Buffett stocks are helping the Oracle of Omaha be a winner even in a down market. All are generating solid returns in 2022.

3 Recession-Proof Dividend Stocks to Buy

By Bob Ciura, Sure Dividend Apr 8, 2022

ABM Industries, Bristol-Myers and UGI are three examples of companies that saw earnings-per-share grow by high rates during the 2007 to 2009 period. All three companies have extensive dividend growth track records and each stock yields higher than what the S&P 500 is paying.

Best Stocks for 2022: Bristol-Myers Squibb Isn’t Done Growing

By Sure Dividend Apr 8, 2022

It's been a great year for Bristol-Myers Squibb this year, but it's not too late to jump in. BMY stock offers a respectable dividend.

7 Biotech Stocks to Buy With Key Catalysts for April

By Shanthi Rexaline Apr 5, 2022

Biotech stocks are very sensitive to some key catalysts such as the FDA decision date, aka PDUFA date, clinical readouts/presentations and Adcom meeting. The month of April will see some companies belonging to the sector seeing some of these make-or-break catalysts.

7 No-Brainer Stocks to Buy for April

By Chris Lau, InvestorPlace Contributor Apr 4, 2022

Start your stock scan with companies showing strong quant scores in value, growth and quality, then buy those with strong catalysts.

7 Michael Burry Stocks to Buy as ‘The Big Short’ Investor Makes Moves

By Thomas Niel, InvestorPlace Contributor Mar 17, 2022

So, which names now make up the Michael Burry stocks? Let's dive in, and check out these seven, the six that are U.S.-based, plus one foreign stock you can buy over-the-counter (OTC): Bristol-Myers Squibb (NYSE:BMY) CoreCivic (NYSE:CXW) Fidelity National Financial (NYSE:FNF) General Dynamics (NYSE:GD) Geo Group (NYSE:GEO) Imperial Brands (OTCMKTS:IMBBY) AEA-Bridges Impact (NYSE:IMPX)

Bristol-Myers Squibb (BMY)

7 Screaming Buy Stock Picks to Beat the September Market Slump

Biotech Stocks Stand to Benefit as Biden Announces Support for Industry

Bristol-Myers Squibb (BMY) Stock Jumps 8% as FDA Approves Psoriasis Treatment

7 Blue-Chip Stocks to Buy Before the Bull Market Returns

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Bristol-Myers Squibb (BMY)

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

BMY Stock Predictions, Articles, and Bristol-Myers Squibb News

Subscriber Sign in